Related Experiment Video
Updated: Jun 2, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Malignant pleural mesothelioma
Siva Raja1, Sudish C Murthy, David P Mason
1Department of Cardiothoracic Surgery, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. rajas@ccf.org
Abstract:
Malignant pleural mesothelioma (MPM) is a relatively rare thoracic malignancy accounting for about 2000-3000 new cases per year. This cancer has been increasing in incidence and is strongly associated with asbestos exposure. Also, it is characterized by insidious growth and clinical presentation at an advanced stage of disease. In the past, the treatment of this disease was limited to marginally effective chemotherapy and morbid surgery. This review explores the clinical presentation of MPM, its diagnostic approach and the relevant and recent studies that define the role of chemotherapy, radiation, and various surgical options. Currently, even with aggressive surgical interventions and multimodality strategies, cure remains elusive, although life prolongation has been achieved. Additionally, promising new therapies and interventions that are currently being studied are introduced in this review.
Insights
Malignant pleural mesothelioma (MPM), a rare cancer linked to asbestos, presents challenges in treatment. While current therapies offer life extension, research into new treatments is ongoing for this aggressive thoracic malignancy.
Area of Science:
- Oncology
- Thoracic Surgery
- Environmental Medicine
Background:
- Malignant pleural mesothelioma (MPM) is a rare thoracic cancer with increasing incidence.
- Strongly associated with asbestos exposure, MPM often presents at advanced stages.
- Past treatments for MPM included limited chemotherapy and invasive surgery.
Purpose of the Study:
- To review the clinical presentation and diagnostic approaches for MPM.
- To explore current treatment modalities including chemotherapy, radiation, and surgery.
- To introduce promising new therapies under investigation for MPM.
Main Methods:
- Literature review of clinical presentation, diagnosis, and treatment of MPM.
- Analysis of recent studies on chemotherapy, radiation, and surgical interventions.
- Inclusion of emerging therapeutic strategies.
Main Results:
- MPM diagnosis is often delayed due to insidious growth.
- Current multimodality treatments can prolong life but rarely achieve cure.
- Aggressive surgical interventions and chemotherapy show limited efficacy.
Conclusions:
- Despite advancements, curative treatment for MPM remains a significant challenge.
- Multimodality strategies offer survival benefits but not a cure.
- Ongoing research into novel therapies holds promise for improved MPM outcomes.
More Related Videos
Related Concept Videos
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pleura of the Lungs
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumothorax-II
Clinical Manifestations:

